Manulife (Manufacturers Life Insurance)’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Sell |
24,419
-1,272
| -5% | -$11.2K | ﹤0.01% | 2519 |
|
|
2025
Q1 | $276K | Sell |
25,691
-1,902
| -7% | -$20.5K | ﹤0.01% | 2371 |
|
|
2024
Q4 | $353K | Sell |
27,593
-35
| -0.1% | -$448 | ﹤0.01% | 2386 |
|
|
2024
Q3 | $763K | Sell |
27,628
-30
| -0.1% | -$828 | ﹤0.01% | 2057 |
|
|
2024
Q2 | $802K | Buy |
27,658
+3,485
| +14% | +$101K | ﹤0.01% | 1965 |
|
|
2024
Q1 | $1.08M | Buy |
24,173
+957
| +4% | +$42.7K | ﹤0.01% | 1826 |
|
|
2023
Q4 | $901K | Hold |
23,216
| – | – | ﹤0.01% | 1852 |
|
|
2023
Q3 | $683K | Buy |
23,216
+22
| +0.1% | +$647 | ﹤0.01% | 1972 |
|
|
2023
Q2 | $1.48M | Buy |
23,194
+11,244
| +94% | +$715K | ﹤0.01% | 1501 |
|
|
2023
Q1 | $564K | Buy |
11,950
+972
| +9% | +$45.9K | ﹤0.01% | 1936 |
|
|
2022
Q4 | $735K | Buy |
10,978
+53
| +0.5% | +$3.55K | ﹤0.01% | 1761 |
|
|
2022
Q3 | $1.61M | Sell |
10,925
-63
| -0.6% | -$9.3K | ﹤0.01% | 1436 |
|
|
2022
Q2 | $1.46M | Buy |
10,988
+1,847
| +20% | +$246K | ﹤0.01% | 1498 |
|
|
2022
Q1 | $961K | Buy |
9,141
+8,250
| +926% | +$867K | ﹤0.01% | 1777 |
|
|
2021
Q4 | $135 | Buy |
891
+140
| +19% | +$21 | ﹤0.01% | 3004 |
|
|
2021
Q3 | $222K | Buy |
+751
| New | +$222K | ﹤0.01% | 2909 |
|